Aurinia Pharmaceuticals
AUPH
AUPH
71 hedge funds and large institutions have $176M invested in Aurinia Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 52 funds opening new positions, 13 increasing their positions, 5 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
8.39% more ownership
Funds ownership: 21.72% → 30.11% (+8.4%)
35% less call options, than puts
Call options by funds: $6.29M | Put options by funds: $9.66M
Holders
71
Holding in Top 10
–
Calls
$6.29M
Puts
$9.66M
Top Buyers
| 1 | +$42.9M | |
| 2 | +$13.2M | |
| 3 | +$9.18M | |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$7.34M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
+$5.8M |
Top Sellers
| 1 | -$6.81M | |
| 2 | -$5.21M | |
| 3 | -$4.4M | |
| 4 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$2.99M |
| 5 |
SG Americas Securities
New York
|
-$784K |